-
Thermo Fisher announces comprehensive myeloid assay available in 2020 to run on the Ion Torrent Genexus System at the 61st American Society of Hematology (ASH) Annual Meeting & Exposition
Dec 4, 2019
-
Webinar that will discuss how small interfering RNA (siRNA) molecules can be used to selectively suppress hepatic genes in an in vitro liver model.
Dec 8, 2019
-
Dec 2, 2019
-
Dec 2, 2019
-
NiceLabel's solution will support a worldwide standardized labeling process for Boehringer Ingelheim, a global pharmaceutical company.
Dec 2, 2019
-
PK Submit generates PK CDISC domains automatically, allowing sponsors to file regulatory submissions faster, while also improving data organization and compliance
Nov 20, 2019
-
mRNA Day is being celebrated in the City of San Diego following a proclamation in honor of Maravai LifeSciences and the grand opening of its new headquarters in the City. A leader in providing reagents to researchers, biotherapeutics manufacturers and OEM partners worldwide; Maravai invested $40 million into the 105,000 square-foot headquarters located in Sorrento Valley, which features a 50,000 square foot manufacturing facility with five state-of-the-art cleanrooms for TriLink BioTechnologies, a leader in the synthesis of highly modified nucleic acids including oligonucleotides and messenger RNA (mRNA) for research, diagnostics, and therapeutic applications.
Maravai’s investment creates five new manufacturing suites for TriLink that meet the FDA’s Current Good Manufacturing Practices (cGMP) requirements, which can help TriLink increase production of complex materials like mRNA. mRNA is on track to become one of the fastest growing segments of the drug industry and has the potential to treat almost any disease. With its increased cGMP capacity, TriLink can help its global customers bring their biomedical breakthroughs based on mRNA and other modified nucleic acids through clinical trials faster and accelerate improvements in human health care.
Nov 19, 2019
-
Nov 19, 2019
-
Accumen has acquired three companies this year, allowing it to generate significant additional value for hospitals and health system, commercial laboratory, and health plan clients
Nov 19, 2019
-
Nov 12, 2019
-
Nov 12, 2019
-
Proscia, a leading provider of digital pathology software, announces the Fall 2019 release of its Concentriq platform, along with a global collaboration with Dell Technologies, to help life sciences companies accelerate the adoption of digital pathology at an enterprise scale.
Nov 11, 2019
-
Proscia, a leading provider of digital pathology software, has been named to the CNBC Upstart 100, an exclusive list of venture-backed startups that have the potential to transform industries and become tomorrow’s household names. Proscia was selected from hundreds of nominees globally for its work towards delivering artificial intelligence applications to improve the quality and speed of cancer diagnosis.
Nov 11, 2019
-
QuantuMDx & SpeeDx Pty Ltd are collaborating with FIND to assess the feasibility of developing rapid, low-cost, point of care diagnostic tests for common STIs.
Nov 7, 2019
-
UK-based Bond Digital Health is predicting significant growth in 2020 on the back of inroads made into the global diagnostics market. The digital health company, based in Cardiff, Wales, has doubled its 2020 revenue predictions from £1.5m ($1.93m US) to more than £3m ($3.86m US).
Nov 4, 2019
-
Experienced pharma business strategist excited by potential of glycoscience.
Oct 29, 2019
-
Oct 30, 2019
-
Presentations demonstrate how to employ real-world evidence to compare the cost-effectiveness and therapeutic benefit of different medical interventions
Oct 31, 2019
-
ECGmd is now recognized as a medical device in Europe, capable of providing medical-grade ECG output from Shimmer’s wearable sensor
Nov 3, 2019
-
New features include upgraded refreshments and entertainment options, improved compensation, increased donor educational materials, and an expanded company website
Nov 3, 2019